Similar companies
| Company | News Mentions | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
1 66.7% |
 |
Eli Lilly and CompanyLLY |
1 0% |
 |
PfizerPFE |
2 100% |
 |
AstrazenecaAZN |
0 100% |
 |
AbbVieABBV |
2 0% |
Can The Promise Of Profitability And Pipelines Sustain A Recovery For Esperion Therapeutics?
June 13
Millennium Management LLC Sells 2,573,645 Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR)
June 3
Gotham Asset Management LLC Trims Stock Position in Esperion Therapeutics, Inc. (NASDAQ:ESPR)
May 22Month over Month
Est. daily news mentions.
| May 2025 | 0 | |
| Apr 2025 | 0 | |
| Mar 2025 | 0 | |
| Feb 2025 | 0 | |
| Jan 2025 | 0 |
How often is Esperion Therapeutics mentioned in the news?
Esperion Therapeutics was mentioned an estimated 0 times in online prominent news articles yesterday.
Analyzing News Mentions, how is Esperion Therapeutics performing compared to its industry peers?
Esperion Therapeutics underperforms its industry peers when it comes to News Mentions, ranking dead last.
Has there been an increase or decrease in news mentions of Esperion Therapeutics in the last month?
There has been no significant change in the number of news mentions for Esperion Therapeutics' compared to the last month.
Why is it important to track news mentions for Esperion Therapeutics?
By monitoring mentions in the news for Esperion Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Esperion Therapeutics, ultimately improving their investment strategies.
Sign up and get more insights on Esperion Therapeutics.
